downloadDownload file

downloadDownload file

1/1

2 files

Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes Mellitus

figure

posted on 2020-05-18, 14:49 authored by Ona Kinduryte Schorling, Douglas Clark, Isabella Zwiener, Stefan Kaspers, Jisoo Lee, Hristo Iliev

The above Summary Slide and Plain Language Summary represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

Funding

Boehringer Ingelheim

History

References

https://link.springer.com/article/10.1007/s12325-020-01329-7

Usage metrics

Read the peer-reviewed publication

Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes Mellitus

Advances in Therapy

Advances in Therapy

Categories

Keywords

Adverse drug event Adverse drug reaction Drug side effects Hypoglycemia Ketoacidosis SGLT2 inhibitor Plain Language Summary

Licence

Exports